Article ID,Publication Year,Reference,US$/QALY *,Ratio Description,PubMed ID,Target Population,Intervention Description,Title,Comparator Description,Impact
2018-01-25945,2018,Teljeur 2018 Pediatr Infect Dis J,3.7e+006,Universal vaccination strategy for TB VERSUS Selective vaccination strategy for TB IN Healthy; Age- 0 to 18 years; Gender- Both; Country- Ireland; Other- infants at high risk of exposure to TB infection.,29432385,Healthy; Age- 0 to 18 years; Gender- Both; Country- Ireland; Other- infants at high risk of exposure to TB infection.,Universal vaccination strategy for TB,Economic Evaluation of Selective Neonatal Bacillus Calmette-Guerin Vaccination of High-risk Infants in Ireland.,Selective vaccination strategy for TB,NE
2017-01-24985,2017,Chawla 2017 Bone Joint J,3400,Patellofemoral arthroplasty VERSUS Total knee arthroplasty IN Specific disease- Patellofemoral osteoarthritis; Age- 41 to 64 years; Gender- Both; Country- United States of America (USA).,28768779,Specific disease- Patellofemoral osteoarthritis; Age- 41 to 64 years; Gender- Both; Country- United States of America (USA).,Patellofemoral arthroplasty,Cost effectiveness of patellofemoral versus total knee arthroplasty in younger patients.,Total knee arthroplasty,NE
2017-01-23143,2017,Agus 2017 Crit Care,Cost-Saving,Once-daily simvastatin (at a dose of 80 mg) VERSUS Placebo IN Specific disease- Acute respiratory distress syndrome; Age- Adult; Gender- Both; Country- United Kingdom; Other- Patients were intubated and mechanically ventilated and were within 48 hours of onset of Acute respiratory distress syndrome.,28511660,Specific disease- Acute respiratory distress syndrome; Age- Adult; Gender- Both; Country- United Kingdom; Other- Patients were intubated and mechanically ventilated and were within 48 hours of onset of Acute respiratory distress syndrome.,Once-daily simvastatin (at a dose of 80 mg),Simvastatin for patients with acute respiratory distress syndrome: long-term outcomes and cost-effectiveness from a randomised controlled trial.,Placebo,SE
2016-01-21448,2016,Moran 2016 Value Health,33000,Annual opportunistic aarial fibrillation (AF) screening program VERSUS None IN Specific disease- Atrial fibrillation (AF); Age- >=65 years; Gender- Both; Country- Ireland; Other- with irregular pulse.,27987649,Specific disease- atrial fibrillation; Age- >=65 years; Gender- Both; Country- Ireland; Other- with irregular pulse.,Annual opportunistic aarial fibrillation (AF) screening program,Cost-Effectiveness of a National Opportunistic Screening Program for Atrial Fibrillation in Ireland.,None,NE
2016-01-20504,2016,Danyliv 2016 Diabetologia,Cost-Saving,Screening for gestational diabetes mellitus in general practitioners office VERSUS None IN Healthy; Age- Adult; Gender- Female; Country- Ireland.,26670162,Healthy; Age- Adult; Gender- Female; Country- Ireland.,Screening for gestational diabetes mellitus in general practitioners office,The cost-effectiveness of screening for gestational diabetes mellitus in primary  and secondary care in the Republic of Ireland.,None,SE
2016-01-20504,2016,Danyliv 2016 Diabetologia,Cost-Saving,Screening for gestational diabetes mellitus in hospital VERSUS None IN Healthy; Age- Adult; Gender- Female; Country- Ireland.,26670162,Healthy; Age- Adult; Gender- Female; Country- Ireland.,Screening for gestational diabetes mellitus in hospital,The cost-effectiveness of screening for gestational diabetes mellitus in primary  and secondary care in the Republic of Ireland.,None,SE
2014-01-16432,2014,Gillespie                        2014 Trials,33000,Group follow-up after structured education VERSUS Standard/Usual Care- individual follow-up IN Specific disease- type 1 diabetes; Age- Adult; Gender- Both; Country- Ireland.,24927851,Specific disease- type 1 diabetes; Age- Adult; Gender- Both; Country- Ireland.,Group follow-up after structured education,Cost effectiveness of group follow-up after structured education for type 1 diabetes: a cluster randomised controlled trial.,Standard/Usual Care- individual follow-up,SW
2014-01-15126,2014,Mason 2014 PLoS One,Â ,Prophylactic Antibiotics VERSUS Placebo IN Specific disease- Cellulitis of the Leg; Age- Unknown; Gender- Both; Country- United Kingdom.,24551029,Specific disease- Cellulitis of the Leg; Age- Unknown; Gender- Both; Country- United Kingdom.,Prophylactic Antibiotics,Prophylactic antibiotics to prevent cellulitis of the leg: economic analysis of the PATCH I & II trials.,Placebo,NE
2014-01-15079,2014,Teljeur 2014 Int J Technol Assess Health Care,35000,"Radical prostatectomy VERSUS Standard/Usual Care- Mixture of open and laparoscopic surgical methods in men requiring radical prostatectomy
mix of open and laparoscopic surgery IN Specific disease- Prostate cancer; Age- Adult; Gender- Male; Country- Ireland.",24472222,Specific disease- Prostate cancer; Age- Adult; Gender- Male; Country- Ireland.,Radical prostatectomy,Using prediction intervals from random-effects meta-analyses in an economic model.,"Standard/Usual Care- Mixture of open and laparoscopic surgical methods in men requiring radical prostatectomy
mix of open and laparoscopic surgery",NE
2014-01-14857,2014,Spackman 2014 Eur J Haematol,88000,"Preoperative transfusion VERSUS No preoperative transfusion IN Specific disease- Sickle cell anaemia; Age- Unknown; Gender- Both; Country- Netherlands, England, Ireland, Canada.",24329965,"Specific disease- Sickle cell anaemia; Age- Unknown; Gender- Both; Country- Netherlands, England, Ireland, Canada.",Preoperative transfusion,Cost-effectiveness analysis of preoperative transfusion in patients with sickle cell disease using evidence from the TAPS trial.,No preoperative transfusion,SW
2014-01-14842,2014,Ashby 2014 Lancet,Cost-Saving,Two-layer compression hosiery VERSUS Standard/Usual Care- Four-layer compression bandages IN Specific disease- Venous leg Ulcer; Age- Adult; Gender- Both; Country- England and Northern Ireland.,24315520,Specific disease- Venous leg Ulcer; Age- Adult; Gender- Both; Country- England and Northern Ireland.,Two-layer compression hosiery,"Clinical and cost-effectiveness of compression hosiery versus compression bandages in treatment of venous leg ulcers (Venous leg Ulcer Study IV, VenUS IV): a randomised controlled trial.",Standard/Usual Care- Four-layer compression bandages,SE
2014-01-14512,2014,Candon 2014 Acta Oncol,40000,Adjuvant Lapatinib VERSUS Standard/Usual Care- Trastuzumab IN Healthy; Age-; Gender- Female; Country- Ireland; Other- HER2-positive early-stage breast cancer.,24125103,Healthy; Age-; Gender- Female; Country- Ireland; Other- HER2-positive early-stage breast cancer.,Adjuvant Lapatinib,Modelling the cost-effectiveness of adjuvant lapatinib for early-stage breast cancer.,Standard/Usual Care- Trastuzumab,NE
2013-01-14940,2013,Diwakar 2013 PLoS One,26000,Vesico Amniotic Shunt VERSUS conservative management IN Specific disease- lower urinary tract obstruction; Age- Adult; Gender- Female; Country- United Kingdom.,24376546,Specific disease- lower urinary tract obstruction; Age- Adult; Gender- Female; Country- United Kingdom.,Vesico Amniotic Shunt,Evaluation of the cost effectiveness of vesico-amniotic shunting in the management of congenital lower urinary tract obstruction (based on data from the  PLUTO Trial).,conservative management,NE
2013-01-14776,2013,Gillespie                        2013 BMJ Open,790000,Structured education pulmonary rehabilitation programme (SEPRP) VERSUS Standard/Usual Care IN Specific disease- chronic obstructive pulmonary disease; Age- Adult; Gender- Both; Country- Ireland.,24282243,Specific disease- chronic obstructive pulmonary disease; Age- Adult; Gender- Both; Country- Ireland.,Structured education pulmonary rehabilitation programme (SEPRP),The cost-effectiveness of a structured education pulmonary rehabilitation programme for chronic obstructive pulmonary disease in primary care: the PRINCE cluster randomised trial.,Standard/Usual Care,NE
2013-01-14491,2013,Dallat 2013 BMC Public Health,6300,"Financial incentive for increasing physical activity in the workplace VERSUS None IN Healthy; Age- 19 to 40 years, 41 to 64 years, >=65 years; Gender- Both; Country- Ireland.",24112295,"Healthy; Age- 19 to 40 years, 41 to 64 years, >=65 years; Gender- Both; Country- Ireland.",Financial incentive for increasing physical activity in the workplace,A lesson in business: cost-effectiveness analysis of a novel financial incentive  intervention for increasing physical activity in the workplace.,None,NE
2013-01-11666,2013,Lee 2013 Appl Health Econ Health Policy,Cost-Saving,Romiplostim VERSUS Eltrombopag IN Specific disease- Chronic Immune Thrombocytopenia; Age- Adult; Gender- Both; Country- Ireland.,23857462,Specific disease- Chronic Immune Thrombocytopenia; Age- Adult; Gender- Both; Country- Ireland.,Romiplostim,Cost effectiveness of romiplostim for the treatment of chronic immune thrombocytopenia in Ireland.,Eltrombopag,SE
2013-01-11666,2013,Lee 2013 Appl Health Econ Health Policy,Cost-Saving,Romiplostim VERSUS Standard/Usual Care IN Specific disease- Chronic Immune Thrombocytopenia; Age- Adult; Gender- Both; Country- Ireland.,23857462,Specific disease- Chronic Immune Thrombocytopenia; Age- Adult; Gender- Both; Country- Ireland.,Romiplostim,Cost effectiveness of romiplostim for the treatment of chronic immune thrombocytopenia in Ireland.,Standard/Usual Care,SE
2013-01-11006,2013,Fawsitt 2013 PLoS One,Cost-Saving,Trial of Labour after caeserean (TOLAC) VERSUS Elective repeat ceaserean delivery (ERCD) IN Specific disease- pregnant women; Age- Adult; Gender- Female; Country- Ireland; Other- Previous caeserean delivery.,23484038,Specific disease- pregnant women; Age- Adult; Gender- Female; Country- Ireland; Other- Previous caeserean delivery.,Trial of Labour after caeserean (TOLAC),At what price? A cost-effectiveness analysis comparing trial of labour after previous caesarean versus elective repeat caesarean delivery.,Elective repeat ceaserean delivery (ERCD),SE
2012-01-09908,2012,Hettle                 2012 Respir Med,29000,Tiotropium plus usual care VERSUS Usual care IN Patients with moderate to very severe chronic obstructive pulmonary disease (COPD) in England,23040833,Patients with moderate to very severe chronic obstructive pulmonary disease (COPD) in England,Tiotropium plus usual care,Cost-utility analysis of tiotropium versus usual care in patients with COPD in the UK and Belgium.,Usual care,NE
2012-01-09908,2012,Hettle                 2012 Respir Med,29000,Tiotropium plus usual care VERSUS Usual care IN UK patients with moderate to very severe chronic obstructive pulmonary disease (COPD),23040833,UK patients with moderate to very severe chronic obstructive pulmonary disease (COPD),Tiotropium plus usual care,Cost-utility analysis of tiotropium versus usual care in patients with COPD in the UK and Belgium.,Usual care,NE
1Â 2Â 3Â 4Â 5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
